Seppic expands its range of injectable surfactants with a novel polysorbate for enhanced biologics stability
Biopharmaceuticals offer significant advantages but also formulation challenges. Due to their complexity compared to chemically derived actives, biological ingredients require stabilisation in solution using specialised excipients to maintain full efficacy.
Seppic, leading pharmaceutical excipients manufacturer, has expanded its portfolio of injectable surfactants with the launch of MONTANOX™ 20 HPB – a high purity polysorbate is specifically designed for biological applications.
MONTANOX™ HPB is a range of non-ionic and hydrophilic surfactants that function as emulsifiers for oil-in-water emulsifiers and as solubilisers, stabilisers and anti-aggregants for biologics. With reduced levels of long-chain saturated fatty acids and minimal residual impurities, its optimised composition meets the needs of biopharmaceutical formulators.
By minimising the risk of active ingredient degradation and aggregation, MONTANOX™ 20 HPB enhances the stability and protection of sensitive biologic formulations.